首页> 外国专利> BENZIMIDAZOLE DERIVATIVES AS NAV 1.7 (CALCIUM CHANNEL, VOLTAGE CONTROL, TYPE IX, ALFA SUBGROUP (SCN9A)) - INHIBITORS FOR THE TREATMENT OF PAIN, DYSURIA AND MULTIPLE SCLEROSE

BENZIMIDAZOLE DERIVATIVES AS NAV 1.7 (CALCIUM CHANNEL, VOLTAGE CONTROL, TYPE IX, ALFA SUBGROUP (SCN9A)) - INHIBITORS FOR THE TREATMENT OF PAIN, DYSURIA AND MULTIPLE SCLEROSE

机译:苯甲咪唑衍生物,NAV 1.7(钙离子通道,电压控制,IX型,ALFA子组(SCN9A))-止痛药,痢疾和多发性硬化症的治疗抑制剂

摘要

The present invention provides a medicament for treating a disease involving Nav 1.7 such as neuropathic pain, nociceptive pain, inflammatory pain, small-fiber neuropathy, erythromelalgia, paroxysmal extreme pain disorder, dysuria, and multiple sclerosis, which comprises a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R 1a , R 1d , R 1c and R 1d are hydrogen, halogen, cyano, C 1-4 alkyl, C 1-4 alkoxy, or the like, provided that at least one of R 1a , R 1b , R 1c and R 1d is C 6-10 aryl, C 6-10 aryloxy, or the like, R 2 and R 3 are hydrogen, C 1-6 alkyl, C 3-10 cycloalkyl, or the like, R 4 is hydrogen, C 1-6 alkyl, C 3-7 cycloalkyl, or the like, m is 1, 2 or 3, L is CR 7 R 8 , and R 7 and R 8 are hydrogen, hydroxyl, C 1-4 alkyl, C 1-4 alkoxy, or the like.
机译:本发明提供了用于治疗涉及Nav 1.7的疾病的药物,其包含式(I)的化合物,所述疾病例如神经性疼痛,伤害性疼痛,炎性疼痛,小纤维神经病,红斑狼疮,阵发性极度疼痛疾病,排尿困难和多发性硬化症。 ):或其R 1a,R 1d,R 1c和R 1d为氢,卤素,氰基,C 1-4烷基,C 1-4烷氧基等的盐或其药学上可接受的盐,条件是R 1a中的至少一个R 1b,R 1c和R 1d为C 6-10芳基,C 6-10芳氧基等,R 2和R 3为氢,C 1-6烷基,C 3-10环烷基等, R 4为氢,C 1-6烷基,C 3-7环烷基等,m为1、2或3,L为CR 7 R 8,R 7和R 8为氢,羟基,C 1- 4烷基,C 1-4烷氧基等。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号